Press Release

Cooley Adds Life Sciences Patent Partner in London

May 3, 2016

London – May 3, 2016 – Cooley is again bolstering its UK office with the arrival of Colm Murphy, a highly respected IP partner with more than 20 years of experience. Murphy joins as a member of Cooley's patent counseling & prosecution practice. 

Murphy, formerly a partner at Venner Shipley in its chemical and life sciences practice, is a European Patent Attorney and a Chartered Patent Attorney with a practice covering a broad range of complex IP matters in the life sciences arena. Murphy has strong relationships with clients in the biochemical, pharmaceutical and medical device fields. His practice covers drafting and prosecuting patent applications, European Patent Office oppositions and appeals, freedom-to-operate clearances – as well as advising on IP portfolio/risk management strategies and IP monetization.  

In August 2015, Cooley officially launched its UK patent practice with the arrival  of three patent practitioners from Mintz Levin – a move that was spearheaded by US-based transatlantic patent partner Ivor Elrifi, also formerly of Mintz. 

"I've known of Cooley's market-leading US life sciences patent capabilities for many years and the firm is gaining the same reputation in the UK," Murphy said. "I'm looking forward to enhancing Cooley's international patent practice and contributing to its growth in London." 

"Colm's arrival strengthens our UK patent capabilities and our comprehensive global life sciences practice," said Justin Stock, managing partner of Cooley in the UK. "He has a proven track record of success representing clients in high-profile oppositions before the European Patent Office and providing proactive and commercial solutions in complex matters."  

Murphy received his LLM in IP Litigation from Nottingham Law School; his MSc in IP Law from Queen Mary University of London; and his BA in Natural Sciences from Trinity College Dublin. He has been ranked as a Band 1 patent attorney in Chambers. 

Since opening the London office in January 2015 with 19 partners, Cooley has announced the arrival of eight additional partners including Stephen Rosen and Natasha Kaye from Olswang; life sciences partners John Wilkinson and Nicola Maguire from Reed Smith; Paula Holland from WilmerHale; Louise Delahunty from Sullivan & Cromwell; John Clark from Mayer Brown; and now Colm Murphy from Venner Shipley.

 About Cooley LLP 

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Press Coverage: 

"Cooley Expands London Office With Patent Partner," Law360

"Colm Murphy Joins Cooley," Legal Week (Subscription required)

"Cooley Hires Partner in London," Life Sciences Intellectual Property Review

"Colm Murphy Joins Cooley," The Times of London (Subscription required)

"Firm Recruits Life Sciences Patent Partner in London," New Law Journal

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.